Bio-implants Market
                     Bio-implants Market - Size, Share, Outlook, and Opportunity Analysis, 2020- 
2027
An implant is a medical device, which replaces, supports, and improves 
damaged or existing biological structure. An implant is a man-made device, 
which is inserted into the human body cavity. Bio-implants are medical devices 
that are made from biological cells compatible with human body cells. Eye bio-
implants are used in the treatment of cornea sores or chemical damages in the 
eye. Bio-implants help in management of disease condition and specific drug 
delivery in conditions such as obesity, infections, and musculoskeletal disorders. 
It provides a specific and unique drug delivery for skeletal muscle. Various bio-
implants are developed by key market players operating in the marketwhich 
include cardiovascular implants, dental, spinal, and orthopedic implants. Cardiac 
implants are used in cardiac related surgeries.
Request a sample copy of this report:- 
https://www.coherentmarketinsights.com/insight/request-sample/3050 
The global bio-implants market was valued at US$ 73,947.4 million in 2019 and 
is expected to exhibit a CAGR of 5.7% over the forecast period (2019-2027).
Increasing prevalence of chronic diseases such as cardiovascular diseases 
(CVD) and arthritis is expected to increase the demand for bio-implants, which in 
turn is expected to fuel the bio-implants market growth over the forecast period. 
For instance, according to the World Health Organization (WHO) 2017 statistics, 
cardiovascular diseases accounted for around 17.9 million deaths in 2016. 
Moreover, according to the Centers for Disease Control and Prevention (CDC), in
May 2019, around 54.4 million of U.S. adults were diagnosed with arthritis.
Manufacturers and researchers are focused on developing the advanced 
systems for treating medication resistant epilepsy patients using a deep brain 
stimulation implant similar to a cardiac pacemaker. For instance, in February 
2019, Medtronic launched Deep Brain Stimulation (DBS) implant for reducing 
epileptic seizures.  DBS provides an important surgical treatment option for 
patients, who suffer from epilepsy and do not respond to medication.
Moreover, key players operating in the market are focusing on strategic 
investment in order to develop and commercialize new products and expand its 
market presence. For instance, in February 2019, GT Medical Technologies 
raised US$ 10 million funding to help support commercialization of its GammaTile
Therapy, a bioresorbable implant designed to deliver local doses of radiation to 
patients with brain tumors.
North America is expected to hold the dominant position in the global bio-implant 
market. The major factors driving growth of the market include increasing 
prevalence of chronic diseases and presence of better healthcare infrastructure 
in the region. For instance, according to the American Chiropractic Association, 
2017, about 65 million U.S. population suffer from lower back problems every 
year, and around 8 out of every 10 Americans are expected to suffer from the 
back pain at some point in their life. Additionally, there is increase in number of 
ophthalmic diseases in the U.S. Rising incidence of chronic diseases is expected
to increase demand for the bio-implants. Thus, owing to these factors the North 
America market is expected to witness significant growth over the forecast 
period.
Moreover, in September 2017, DePuy Synthes launched TRUMATCH Titanium 
3D-Printed Implants in the U.S. This is used in facial reconstruction. The new 
products were distributed through an exclusive agreement with Materialise, a 
leader in software solutions and 3D-printing services in the medical and industrial
markets.
Asia Pacific market is expected to be the fastest-growing market over the 
forecast period, owing to high incidence of spinal cord injuries in the region. This 
can be attributed to increasing incidence of road accidents. For instance, 
according to the Tokyo’s Keio University’s February 2019 publication, over 
100,000 patients in Japan were paralyzed due to spinal cord injuries.
Major players operating in the global bio-implants market include Abbott, 
Dentsply Sirona Plc, Medtronic, Stryker Corporation, Zimmer Biomet, B.Braun, 
Cook Medical, C.R. Bard, Edwards Lifesciences, Wright Medical technology, and 
Boston Scientific Corporation.
Get the main link:-  https://www.coherentmarketinsights.com/market-insight/bioimplants-market-
3050  
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/